Legal Intern - Summer jobs in United States
cer-icon
Apply on Employer Site
company-logo

Repligen Corporation · 12 hours ago

Legal Intern - Summer

Repligen Corporation is a life sciences company focused on the development, production, and commercialization of high-value consumable products used in the manufacturing of biological drugs. They are seeking a Legal Intern for Summer 2026 to assist with daily activities in the Legal Department, participate in meetings, and draft legal memoranda while gaining exposure to various legal processes.

AnalyticsBiotechnologyConsumer GoodsHealth CareManufacturingPharmaceutical

Responsibilities

Assist with and participate in the daily activities and special projects of the Legal Department, and benefit from coaching and mentoring by seasoned in-house attorneys
Attend and participate in meetings and presentations
Draft memoranda regarding areas of legal interest to the intern, potentially including commercial compliance, intellectual property, and/or employment law, and receive feedback on the same
Learn the commercial contract process and review contracts
Develop skills with important legal tools and systems
Review and become familiar with Repligen’s policies and internal processes
Develop relationships with organizational leaders and cross-functional stakeholders
Shadow attorneys in important meetings and negotiations

Qualification

Current enrollment in law schoolInterest in biotech lawOrganizational skillsCommunication skillsTeamworkMotivation

Required

Current enrollment in ABA-accredited law school
Strong GPA and academic record
Highly motivated, responsible, and professional approach
Well-developed organizational and communication skills
Ability to work as a member of a team and independently, as experience is gained
Interest in in-house legal work, with a specific interest in biotech, pharmaceutical, or bioprocessing
Desire to learn and develop key legal skills

Preferred

Hybrid work arrangement is preferred; however, fully remote arrangements may be considered

Company

Repligen Corporation

twittertwittertwitter
company-logo
FRAUD ALERT: Please take note that it has come to our attention that individuals purporting to work for Repligen are reaching out to prospective job applicants using fraudulent email addresses.

Funding

Current Stage
Public Company
Total Funding
$1.34B
2023-12-06Post Ipo Debt· $600M
2020-12-07Post Ipo Equity· $312.23M
2019-07-17Post Ipo Debt· $287.5M

Leadership Team

leader-logo
Jason Garland
Chief Financial Officer
linkedin
leader-logo
Rachel Legmann
Senior Director of Technology, Gene Therapy
linkedin
Company data provided by crunchbase